Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RETA stock: Reata Pharmaceuticals Inc

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$24.26
Market Cap
608.7M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
-
P/S
11.99
Dividend %
-
P/CF
12.1
P/FCF
-
Op. Cash Flow
-20.7K
FCF
-1.1
Op. Margin
-6.40%
Net Margin
-7.70%
ROE
1.60%
ROI
0.50%
ROA
-4.30%
EPS Growth
-
Current Ratio
1.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
CRYO-CELL International, Inc. (CCEL) $4.25 - - 29.6M Strong Buy
CYANOTECH CORP (CYAN) $3.60 - - 22.1M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.49 - - 58.4M Strong Buy
AngioDynamics, Inc. (ANGO) $16.62 - - 627.7M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $3.21 - - 8.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More